{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:30:57Z","timestamp":1787812257064,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2014HM064"],"award-info":[{"award-number":["ZR2014HM064"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00213-023-06423-6","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T21:01:37Z","timestamp":1690059697000},"page":"2061-2070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache"],"prefix":"10.1007","volume":"240","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"key":"6423_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12165","volume":"42","author":"OH Ababneh","year":"2014","unstructured":"Ababneh OH, Cetinkaya A, Kulwin DR (2014) Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.\u00a0Clin Exp Ophthalmol\u00a042:254\u2013261","journal-title":"Clinical & experimental ophthalmology"},{"key":"6423_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MRR.0b013e32834df64f","volume":"35","author":"AM Bakheit","year":"2012","unstructured":"Bakheit AM, Liptrot A, Newton R, Pickett AM (2012) The effect of total cumulative dose, number of treatment cycles, interval between injections, and length of treatment on the frequency of occurrence of antibodies to botulinum toxin type A in the treatment of muscle spasticity.\u00a0Int J Rehabil Res 35:36\u201339","journal-title":"International journal of rehabilitation research Internationale Zeitschrift fur Rehabilitationsforschung Revue internationale de recherches de readaptation"},{"key":"6423_CR3","first-page":"Cd002919","volume":"4","author":"R Banzi","year":"2015","unstructured":"Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L (2015) Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.\u00a0Cochrane Database Syst Rev\u00a0\u00a04:Cd002919","journal-title":"The Cochrane database of systematic reviews"},{"key":"6423_CR4","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1468-1331.2010.03070.x","volume":"17","author":"L Bendtsen","year":"2010","unstructured":"Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J (2010) EFNS guideline on the treatment of tension-type headache - report of an EFNS task force.\u00a0Eur J Neurol\u00a017:1318\u20131325","journal-title":"European journal of neurology"},{"key":"6423_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1155\/2014\/410415","volume":"19","author":"L Bittencourt da Silva","year":"2014","unstructured":"Bittencourt da Silva L, Karshenas A, Bach FW, Rasmussen S, Arendt-Nielsen L, Gazerani P (2014) Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study. Pain Res Manag 19:126\u2013132","journal-title":"Pain research & management"},{"key":"6423_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hup.1211","volume":"26","author":"JA Bodkin","year":"2011","unstructured":"Bodkin JA, Allgulander C, Llorca PM, Spann ME, Walker DJ, Russell JM, Ball SG (2011) Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder. Hum Psychopharmacol 26:258\u2013266","journal-title":"Human psychopharmacology"},{"key":"6423_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11940-019-0557-2","volume":"21","author":"R Burch","year":"2019","unstructured":"Burch R (2019) Antidepressants for preventive treatment of migraine.\u00a0Curr Treat Options Neurol 21:18","journal-title":"Current treatment options in neurology"},{"key":"6423_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-021-01254-2","volume":"22","author":"WJ Chen","year":"2021","unstructured":"Chen WJ, Niu JQ, Chen YT, Deng WJ, Xu YY, Liu J, Luo WF, Liu T (2021) Unilateral facial injection of botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice. J Headache Pain 22:38","journal-title":"The Journal of Headache and Pain"},{"key":"6423_CR9","first-page":"1232","volume":"20","author":"Chinese Medical Association","year":"2021","unstructured":"Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, Anxiety Disorder Collaboration Group of Chinese Society of Psychiatry, Editorial Board of Chinese Journal of General Practitioners of Chinese Medical Association, Disease EGoGfPCoNS (2021) Guideline for primary care of generalized anxiety disorder(2021).\u00a0Chin J Gen Pract\u00a020:1232\u20131241","journal-title":"The Chinese Journal of General Practitioners"},{"key":"6423_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ncl.2020.09.014","volume":"39","author":"SY Chiu","year":"2021","unstructured":"Chiu SY, Burns MR, Malaty IA (2021) An update on botulinum toxin in neurology. Neurol Clin 39:209\u2013229","journal-title":"Neurologic clinics"},{"key":"6423_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (London, England) 373:746\u2013758","journal-title":"Lancet (London, England)"},{"key":"6423_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/JXX.0000000000000075","volume":"30","author":"CL Cook","year":"2018","unstructured":"Cook CL, Shedd GC (2018) Diagnosis and treatment of migraine in the patient with depression. J Am Assoc Nurse Pract 30:630\u2013637","journal-title":"Journal of the American Association of Nurse Practitioners"},{"key":"6423_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/toxins6020592","volume":"6","author":"LB da Silva","year":"2014","unstructured":"da Silva LB, Kulas D, Karshenas A, Cairns BE, Bach FW, Arendt-Nielsen L, Gazerani P (2014) Time course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles. Toxins 6:592\u2013607","journal-title":"Toxins"},{"key":"6423_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ane.12906","volume":"137","author":"TP Do","year":"2018","unstructured":"Do TP, Hvedstrup J, Schytz HW (2018) Botulinum toxin: a review of the mode of action in migraine.\u00a0Acta Neurol Scand 137:442\u2013451","journal-title":"Acta neurologica Scandinavica"},{"key":"6423_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.2044-8260.1997.tb01234.x","volume":"36","author":"RC Durham","year":"1997","unstructured":"Durham RC, Allan T, Hackett CA (1997) On predicting improvement and relapse in generalized anxiety disorder following psychotherapy.\u00a0Br J Clin Psychol\u00a036:101\u2013119","journal-title":"The British journal of clinical psychology"},{"key":"6423_CR16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/JCP.0000000000001066","volume":"39","author":"E Finzi","year":"2019","unstructured":"Finzi E, Rosenthal NE (2019) Botulinum toxin therapy of social anxiety disorder: a case series. J Clin Psychopharmacol 39:410\u2013412","journal-title":"Journal of clinical psychopharmacology"},{"key":"6423_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.pain.2010.07.029","volume":"151","author":"P Gazerani","year":"2010","unstructured":"Gazerani P, Au S, Dong X, Kumar U, Arendt-Nielsen L, Cairns BE (2010) Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis. Pain 151:606\u2013616","journal-title":"Pain"},{"key":"6423_CR18","first-page":"65","volume":"17","author":"Group of Head and facial Pain","year":"2011","unstructured":"Group of Head and facial Pain, Association PBotCM (2011) Guidelines for the diagnosis and treatment of migraine in China. Chin J Pain Med 17:65\u201386","journal-title":"Chinese Journal of pain Medicine"},{"key":"6423_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10194-008-0082-2","volume":"10","author":"SM Hamdy","year":"2009","unstructured":"Hamdy SM, Samir H, El-Sayed M, Adel N, Hasan R (2009) Botulinum toxin: could it be an effective treatment for chronic tension-type headache? J Headache Pain 10:27\u201334","journal-title":"The journal of headache and pain"},{"key":"6423_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cercor\/bhn104","volume":"19","author":"A Hennenlotter","year":"2009","unstructured":"Hennenlotter A, Dresel C, Castrop F, Ceballos-Baumann AO, Wohlschl\u00e4ger AM, Haslinger B (2009) The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles. Cereb Cortex 19:537\u2013542","journal-title":"Cerebral cortex"},{"key":"6423_CR21","doi-asserted-by":"publisher","first-page":"e027953","DOI":"10.1136\/bmjopen-2018-027953","volume":"9","author":"CP Herd","year":"2019","unstructured":"Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives NJ, Clarke CE, Sinclair AJ (2019) Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ open 9:e027953","journal-title":"BMJ open"},{"key":"6423_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/B978-0-444-52002-9.00019-X","volume":"106","author":"RB Hidalgo","year":"2012","unstructured":"Hidalgo RB, Sheehan DV (2012) Generalized anxiety disorder. Handbook of clinical neurology 106:343\u2013362","journal-title":"Handbook of clinical neurology"},{"key":"6423_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/01.yic.0000194375.42589.c3","volume":"21","author":"S Kasper","year":"2006","unstructured":"Kasper S, Spadone C, Verpillat P, Angst J (2006) Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis. Int Clin Psychopharmacol 21:105\u2013110","journal-title":"International clinical psychopharmacology"},{"issue":"Suppl 8","key":"6423_CR24","first-page":"11","volume":"63","author":"MB Keller","year":"2002","unstructured":"Keller MB (2002) The long-term clinical course of generalized anxiety disorder. The J Clin Psychiatry 63(Suppl 8):11\u201316","journal-title":"The Journal of clinical psychiatry"},{"key":"6423_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1526-4610.2005.05101.x","volume":"45","author":"AE Lake 3rd","year":"2005","unstructured":"Lake AE 3rd, Rains JC, Penzien DB, Lipchik GL (2005) Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache 45:493\u2013506","journal-title":"Headache"},{"key":"6423_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1473-2165.2009.00419.x","volume":"8","author":"MB Lewis","year":"2009","unstructured":"Lewis MB, Bowler PJ (2009) Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 8:24\u201326","journal-title":"Journal of cosmetic dermatology"},{"key":"6423_CR27","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.3390\/toxins7093818","volume":"7","author":"S Luvisetto","year":"2015","unstructured":"Luvisetto S, Gazerani P, Cianchetti C, Pavone F (2015) Botulinum toxin type A as a therapeutic agent against headache and related disorders. Toxins 7:3818\u20133844","journal-title":"Toxins"},{"key":"6423_CR28","first-page":"745","volume":"52","author":"A Lyu","year":"2019","unstructured":"Lyu A, Fan Y, Tang L, Guo X, Liu J, Huang Y, Zhou X, Hu H, Liu C, Luo W (2019) Clinical study on the efficacy and safety of botulinum toxin A in the treatment in Parkinson\u2019s disease with depression. Chin J Neurol 52:745\u2013751","journal-title":"The Chinese Journal of Neurology"},{"key":"6423_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","volume":"75","author":"M Magid","year":"2014","unstructured":"Magid M, Reichenberg JS, Poth PE, Robertson HT, LaViolette AK, Kruger TH, Wollmer MA (2014) Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry 75:837\u2013844","journal-title":"The Journal of clinical psychiatry"},{"key":"6423_CR30","first-page":"299","volume":"115","author":"A May","year":"2018","unstructured":"May A (2018) Hints on diagnosing and treating headache. Deutsches Arzteblatt international 115:299\u2013308","journal-title":"Deutsches Arzteblatt international"},{"key":"6423_CR31","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","volume":"29","author":"J Meng","year":"2009","unstructured":"Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR, Lawrence GW, Dolly JO (2009) Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci : the official journal of the Society for Neuroscience 29:4981\u20134992","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"6423_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pmr.2015.01.001","volume":"26","author":"N Murinova","year":"2015","unstructured":"Murinova N, Krashin D (2015) Chronic daily headache. Phys Med Rehabil Clin N Am 26:375\u2013389","journal-title":"Physical medicine and rehabilitation clinics of North America"},{"issue":"Suppl 2","key":"6423_CR33","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.euroneuro.2006.04.003","volume":"16","author":"D Nutt","year":"2006","unstructured":"Nutt D, Argyropoulos S, Hood S, Potokar J (2006) Generalized anxiety disorder: a comorbid disease. Eur Neuropsychopharmacol 16(Suppl 2):S109\u2013S118","journal-title":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology"},{"key":"6423_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0035-3787(05)85119-7","volume":"161","author":"J Olesen","year":"2005","unstructured":"Olesen J (2005) The international classification of headache disorders. Rev Neurol 161:689\u2013691","journal-title":"Revue neurologique"},{"key":"6423_CR35","first-page":"881","volume":"26","author":"Pain and Sensory Disorders Group NBoCMDA","year":"2020","unstructured":"Pain and Sensory Disorders Group NBoCMDA (2020) Chinese expert consensus on the diagnosis and treatment of migraine and depressive disorder comorbidity. Chin J Pain Med 26:881\u2013890","journal-title":"Chinese Journal of pain Medicine"},{"key":"6423_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/archpsyc.65.5.551","volume":"65","author":"M Pollack","year":"2008","unstructured":"Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R (2008) Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 65:551\u2013562","journal-title":"Archives of general psychiatry"},{"key":"6423_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.31887\/DCNS.2015.17.2\/proybyrne","volume":"17","author":"P Roy-Byrne","year":"2015","unstructured":"Roy-Byrne P (2015) Treatment-refractory anxiety; definition, risk factors, and treatment challenges. Dialogues Clin Neurosci 17:191\u2013206","journal-title":"Dialogues in clinical neuroscience"},{"issue":"7","key":"6423_CR38","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/ijerph17072393","volume":"17","author":"G Serafini","year":"2020","unstructured":"Serafini G, Parisi VM, Aguglia A (2020) A specific inflammatory profile underlying suicide risk? Systematic review of the main literature findings. Int J Environ Res Public Health 17(7):2393","journal-title":"International journal of environmental research and public health"},{"key":"6423_CR39","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4088\/JCP.11m07493","volume":"73","author":"DJ Stein","year":"2012","unstructured":"Stein DJ, Ahokas A, Albarran C, Olivier V, Allgulander C (2012) Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study. J Clin Psychiatry 73:1002\u20131008","journal-title":"The Journal of clinical psychiatry"},{"key":"6423_CR40","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMcp1502514","volume":"373","author":"MB Stein","year":"2015","unstructured":"Stein MB, Sareen J (2015) CLINICAL PRACTICE. Generalized anxiety disorder. N Eng J Med 373:2059\u20132068","journal-title":"The New England journal of medicine"},{"key":"6423_CR41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/WNF.0b013e3181a8c84f","volume":"32","author":"S Tarlaci","year":"2009","unstructured":"Tarlaci S (2009) Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol 32:254\u2013258","journal-title":"Clinical neuropharmacology"},{"key":"6423_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jad.2018.04.047","volume":"236","author":"S Telang","year":"2018","unstructured":"Telang S, Walton C, Olten B, Bloch MH (2018) Meta-analysis: second generation antidepressants and headache. J Affect Disord 236:60\u201368","journal-title":"Journal of affective disorders"},{"key":"6423_CR43","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/archpsyc.63.12.1358","volume":"63","author":"J Tiihonen","year":"2006","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63:1358\u20131367","journal-title":"Archives of general psychiatry"},{"key":"6423_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7861\/clinmedicine.15-3-273","volume":"15","author":"MW Weatherall","year":"2015","unstructured":"Weatherall MW (2015) Drug therapy in headache. Clin Med 15:273\u2013279","journal-title":"Clinical medicine (London, England)"},{"key":"6423_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1192\/S0007125000296219","volume":"159","author":"HU Wittchen","year":"1991","unstructured":"Wittchen HU, Essau CA, Krieg JC (1991) Anxiety disorders: similarities and differences of comorbidity in treated and untreated groups. Br J Psychiatry 159:23\u201333","journal-title":"The British journal of psychiatry"},{"issue":"Suppl 8","key":"6423_CR46","first-page":"24","volume":"63","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU, Kessler RC, Beesdo K, Krause P, H\u00f6fler M, Hoyer J (2002) Generalized anxiety and depression in primary care: prevalence, recognition, and management. J\u00a0Clin Psychiatry 63(Suppl 8):24\u201334","journal-title":"The Journal of clinical psychiatry"},{"key":"6423_CR47","doi-asserted-by":"publisher","first-page":"24173","DOI":"10.1038\/s41598-021-03713-x","volume":"11","author":"MA Wollmer","year":"2021","unstructured":"Wollmer MA, Makunts T, Kr\u00fcger THC, Abagyan R (2021) Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety. Sci Rep 11:24173","journal-title":"Scientific reports"},{"key":"6423_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2021.06.071","volume":"569","author":"A Yesudhas","year":"2021","unstructured":"Yesudhas A, Radhakrishnan RK, Sukesh A, Ravichandran S, Manickam N, Kandasamy M (2021) BOTOX\u00ae counteracts the innate anxiety-related behaviours in correlation with increased activities of key antioxidant enzymes in the hippocampus of ageing experimental mice. Biochem Biophys Res Commun 569:54\u201360","journal-title":"Biochemical and biophysical research communications"},{"key":"6423_CR49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1192\/bjp.168.3.308","volume":"168","author":"KA Yonkers","year":"1996","unstructured":"Yonkers KA, Warshaw MG, Massion AO, Keller MB (1996) Phenomenology and course of generalised anxiety disorder. Bri J Psychiatry 168:308\u2013313","journal-title":"The British journal of psychiatry : the journal of mental science"},{"key":"6423_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/00207454.2016.1196687","volume":"127","author":"H Zhang","year":"2017","unstructured":"Zhang H, Zhang H, Wei Y, Lian Y, Chen Y, Zheng Y (2017) Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study. Int J Neurosci 127:285\u2013290","journal-title":"The International journal of neuroscience"},{"key":"6423_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1468-1331.2003.00551.x","volume":"10","author":"JA Zwart","year":"2003","unstructured":"Zwart JA, Dyb G, Hagen K, \u00d8deg\u00e5rd KJ, Dahl AA, Bovim G, Stovner LJ (2003) Depression and anxiety disorders associated with headache frequency. The Nord-Tr\u00f8ndelag Health Study. Eur J Neurol 10:147\u2013152","journal-title":"European journal of neurology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06423-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T15:53:59Z","timestamp":1702828439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06423-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6423"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06423-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}